European Drug Report 2020: Key Issues

Table of contents

Table of contents

• Introductory note
• Acknowledgements
• COVID-19 pandemic and the drug situation
• Europe's drug situation up to 2020: Key issues identified
  • Large drug shipments are increasingly intercepted
  • Cocaine’s role in Europe’s drug problem is increasing
  • The potential for increased heroin use and existing  harms raise concerns
  • Understanding the public health impact of high-potency  cannabis and new products
  • Increased and diverse drug production within Europe
  • Continuing availability of high-strength MDMA products  highlights need for greater user awareness
  • Growing complexity in the drug market poses regulatory  challenges and health risks
  • New tools and innovative strategies are needed to support  the scaling-up of hepatitis C treatment
  • Drug overdose is increasingly associated with  an ageing population
  • New psychoactive substances have become  a more persistent problem
  • Appearance of new synthetic opioids is a worrying example  of continuing market adaptability
• Annex: National data tables